metofenazate has been researched along with amitriptyline in 1 studies
*Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. [MeSH]
*Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korkina, MV; Marilov, VV | 1 |
1 other study(ies) available for metofenazate and amitriptyline
| Article | Year |
|---|---|
[Psychosomatic disorders of the colon].
Topics: Adolescent; Adult; Amitriptyline; Colonic Diseases, Functional; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neurotic Disorders; Phenothiazines; Psychophysiologic Disorders; Psychotherapy | 1989 |